Skip to content

Vamana Dhauti as an add on treatment in Depression- a Pilot RCT

Feasibility and Tolerability of Vamana Dhauti as an add-on treatment in patients with Depression: a Pilot Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054596
Enrollment
24
Registered
2023-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features Health Condition 2: F330- Major depressive disorder, recurrent, mild Health Condition 3: F331- Major depressive disorder, recurrent, moderate Health Condition 4: F339- Major depressive disorder, recurrent, unspecified Health Condition 5: F320- Major depressive disorder, singleepisode, mild Health Condition 6: F321- Major depressive disorder, singleepisode, moderate Health Condition 7: F322- Major dep

Interventions

Intervention1: Vamana Dhauti: Vamana Dhauti once on day one followed by Shavasana rest and six days of yoga practice from day two to day seven Control Intervention1: Shavasana only: Shavasana rest onl

Sponsors

Dr Aditi Garg
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with depressive disorder according to ICD11 or DSM V - TR Patients with stable medications for the last one month

Exclusion criteria

Exclusion criteria: Any present diagnosis of gastric or duodenal ulcers, Hypertension, Cardiovascular disorders, Alcohol use associated with oesophageal varices, hernia, pregnant women, Co-morbidities like Diabetes associated with increased intra ocular pressure Patients practising yoga, meditation or any mind body practice in last one month Patients with risk of harm Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Feasibility, tolerability of Vamana Dhauti HRV changes at baseline, during and after the procedure (day 01)Timepoint: At baseline, after the procedure (day01)

Secondary

MeasureTime frame
HDRS-17 scoresTimepoint: Baseline and after seven days

Countries

India

Contacts

Public ContactDr Kishore Kumar Ramakrishna

NIMHANS

ayurkishore@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026